Aspen Aerogels Q4 revenue misses; initiates review

Aspen Aerogels

25/02/2026 11:41

Overview

Sustainability tech firm's Q4 revenue fell, missing analyst expectations

Company reported Q4 net loss of $72.9 mln, compared to net income last year

Aspen initiated strategic review to strengthen long-term competitive position

Outlook

Aspen expects Q1 2026 revenue between $35 mln and $40 mln

Company anticipates Q1 2026 net loss between $20 mln and $23 mln

Aspen projects Q1 2026 adjusted EBITDA between $(10) mln and $(13) mln

Result Drivers

REGULATORY CHANGES - Significant reduction in customer demand due to changes in regulatory frameworks and incentive programs

RESTRUCTURING COSTS - Q4 results included restructuring and demobilization costs, impacting net loss

STRATEGIC REVIEW - Initiated strategic review to strengthen long-term competitive positioning

Company press release: ID:nGNX6BkZPV

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Miss
$41.30 mln
$44.25 mln (6 Analysts)
Q4 EPS
-$0.88
Q4 Net Income
-$72.90 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the specialty chemicals peer group is "buy"

Wall Street's median 12-month price target for Aspen Aerogels Inc is $6.50, about 82.6% above its February 24 closing price of $3.56

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)